Public information according to the provisions of Directive 2001/18/EC
File:
Trial reference:
Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated with Variants in the RPGR gene
Doc type: